Try our Advanced Search for more refined results
India Globalization Capital, Inc. v. Apogee Financial Investments, Inc.
Case Number:
1:21-cv-01131
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 10, 2023
Cannabinoid Co. Settles Spoiled Acquisition Suit
A New York federal judge has dismissed a lawsuit over whether Apogee Financial Investments Inc. held up its end of an acquisition agreement after cannabinoid research company IGC Pharma Inc. secured an early win on a number of claims in the suit.
-
July 25, 2023
Cannabinoid Co. Wins Most Claims In Purchase Contract Suit
A New York federal judge has granted cannabinoid research company IGC Pharma Inc. an early win on most claims in a suit alleging Apogee Financial Investments Inc. failed to hold up its end of an acquisition agreement, leaving only Apogee's counterclaim that IGC also breached the agreement by paying it in restricted stock.
-
March 07, 2022
CBD Co. Gets Claims Trimmed Over Failed Biz Transaction
A New York federal judge trimmed counterclaims lodged against cannabis company India Globalization Capital by Apogee Financial Investments, which claimed the cannabinoid research company caused the downfall of Apogee, its principal and a brokerage it had purchased.
-
May 24, 2021
CBD Co. Seeks To Trim Claims Over Failed Biz Transaction
CBD company India Globalization Capital has urged a New York federal judge to ax most claims sprung by Apogee Financial Investments blaming the cannabinoid research company for the downfall of a brokerage it bought, arguing that it never owed the investment company any fiduciary duty.
-
April 29, 2021
CBD Co. Hit With $12M Fraud Suit Over Failed Biz Transaction
India Globalization Capital took ownership of a brokerage company owned by Apogee Financial Investments in an effort to break into the cannabis industry, but it didn't live up to its financial promises, leading to the downfall of the brokerage, according to Apogee's New York federal lawsuit filed Thursday seeking $12 million.